This contribution analyzes the impact of digital health care on the European Union (EU) legislative framework concerning cross-border health care and the related reimbursement rules. Traditionally, cross-border health care concerns a situation where a patient crosses an internal EU border. However, with the introduction of digital health care, a patient is no longer required to move to receive cross-border health care. Under EU law, patients have two independent rights to reimbursement for medical expenses in a cross-border situation, embedded in Regulation 833/2004 on Social Security Systems and the Patients’ Rights Directive 2011/24. A striking difference between the Regulation and the Directive lies in the fact that the Directive explicitly addresses digital health care, referring to “telemedicine,” whereas the Regulation does not. Also, whereas under the Directive, cross-border health care is reimbursed at the home-state rate, under the Regulation, cross-border health care is reimbursed at the host-state rate, leaving room for forum shopping for advantageous reimbursement rates. However, as the Regulation refers to “travel” and “temporary residence” in the host state, such forum shopping would not be available for digital cross-border health care. This contribution focusses on these discrepancies between the Directive and the Regulation, and specifically on the consequences for the reimbursement of patients benefitting from cross-border digital health care. Digital and physical cross-border health care reimbursement opportunities are compared, and based on the outcomes, an assessment is made as to whether the Regulation should be updated to be suitable for digital health care.